142217-78-5

  • 产品名称:(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
  • 分子式:C52H49N5O5
  • 纯度:99%
  • 分子量:823.992
询价

产品详情

外观:Colorless transparent liquid

 

  • Molecular Formula:C52H49N5O5
  • Molecular Weight:823.992
  • Appearance/Colour:Colorless transparent liquid 
  • Refractive Index:1.645 
  • PKA:13.87±0.70(Predicted) 
  • PSA:112.78000 
  • Density:1.23 g/cm3 
  • LogP:9.61500 

(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol(Cas 142217-78-5) Usage

Uses

Entecavir-?5 is used in the preparation of the anti-?HBV drug Entecavir.

InChI:InChI=1/C52H49N5O5/c1-59-43-29-27-42(28-30-43)52(40-23-13-5-14-24-40,41-25-15-6-16-26-41)56-51-54-49-47(50(55-51)62-34-39-21-11-4-12-22-39)53-36-57(49)45-31-46(61-33-38-19-9-3-10-20-38)44(48(45)58)35-60-32-37-17-7-2-8-18-37/h2-30,36,44-46,48,58H,31-35H2,1H3,(H,54,55,56)/t44-,45-,46-,48?/m0/s1

142217-78-5 Relevant articles

Improved entecavir intermediate synthesis process and improved entecavir synthesis process

-

Paragraph 0012; 0042-0047; 0051; 0053; 0055; 0057; 0058, (2020/10/14)

The invention discloses an improved ente...

BMS-200475, a novel carbocyclic 2'-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro

Bisacchi,Chao,Bachard,Daris,Innaimo,Jacobs,Kocy,Lapointe,Martel,Merchant,Slusarchyk,Sundeen,Young,Colonno,Zahler

, p. 127 - 132 (2007/10/03)

BMS-200475, a never carbocyclic analog o...

Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines

-

, (2008/06/13)

Antiviral activity is exhibited by compo...

142217-78-5 Process route

[1S-(1α,2β,3α,5β)]-5-(2-amino-6-benzyloxy-9H-purin-9-yl)-3-benzyloxy-2-(benzyloxy)methyl-cyclopentanol
142217-77-4

[1S-(1α,2β,3α,5β)]-5-(2-amino-6-benzyloxy-9H-purin-9-yl)-3-benzyloxy-2-(benzyloxy)methyl-cyclopentanol

mono-4-methoxytrityl chloride
14470-28-1

mono-4-methoxytrityl chloride

(1S,2S,3S,5S)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-benzyloxy-9H-purin-9-yl]-3-benzyloxy-2-[(benzyloxy)methyl]cyclopentanol
142217-78-5

(1S,2S,3S,5S)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-benzyloxy-9H-purin-9-yl]-3-benzyloxy-2-[(benzyloxy)methyl]cyclopentanol

Conditions
Conditions Yield
With dmap; TEA; In dichloromethane;
82%
With dmap; triethylamine; In dichloromethane; at 20 - 30 ℃; for 1h; Concentration; Inert atmosphere;
 
Benzyloxymethyl chloride
3587-60-8

Benzyloxymethyl chloride

(1S,2S,3S,5S)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-benzyloxy-9H-purin-9-yl]-3-benzyloxy-2-[(benzyloxy)methyl]cyclopentanol
142217-78-5

(1S,2S,3S,5S)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-benzyloxy-9H-purin-9-yl]-3-benzyloxy-2-[(benzyloxy)methyl]cyclopentanol

Conditions
Conditions Yield
Multi-step reaction with 6 steps
1: tetrahydrofuran / -78 - -65 °C
2: 1.) diisopinylcampheylborane (prepared from (+)-α-pinene), 2.) aq. NaOH, H2O2 / 1.) THF, -65 to -78 deg C
3: VO(acac)2, t-BuOOH / CH2Cl2
4: NaH, Bu4NI / dimethylformamide
5: 60 percent / LiH / dimethylformamide / 2 h / 125 °C
6: 82 percent / TEA, DMAP / CH2Cl2
With tert.-butylhydroperoxide; dmap; sodium hydroxide; bis(acetylacetonate)oxovanadium; (-)-diisopinocampheylborane; TEA; dihydrogen peroxide; tetra-(n-butyl)ammonium iodide; lithium hydride; sodium hydride; In tetrahydrofuran; dichloromethane; N,N-dimethyl-formamide;
 

142217-78-5 Upstream products

  • 142217-77-4
    142217-77-4

    [1S-(1α,2β,3α,5β)]-5-(2-amino-6-benzyloxy-9H-purin-9-yl)-3-benzyloxy-2-(benzyloxy)methyl-cyclopentanol

  • 14470-28-1
    14470-28-1

    mono-4-methoxytrityl chloride

  • 3587-60-8
    3587-60-8

    Benzyloxymethyl chloride

  • 39939-07-6
    39939-07-6

    5-(benzyloxymethyl)cyclopentadiene

142217-78-5 Downstream products

  • 142217-79-6
    142217-79-6

    (2R,3S,5S)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-benzyloxy-9H-fluoren-9-yl]-3-benzyloxy-2-[(benzyloxy)methyl]cyclopentanone

  • 142217-80-9
    142217-80-9

    6-(benzyloxy)-9-((1S,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylidenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine

  • 142217-69-4
    142217-69-4

    entecavir

  • 142217-81-0
    142217-81-0

    2-amino-1,9-dihydro-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-6H-purin-6-one